My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Catalent, Inc. Common Stock (NY:CTLT)

63.48 UNCHANGED

Last Price Updated: 7:00 PM EST, Dec 17, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Catalent, Inc. Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

These 2 Stocks Are Making a Pop on Monday ↗

February 06, 2023

Even as markets were under pressure, market participants found things to be happy about with these two companies.

Via The Motley Fool

NEM Stock Alert: What to Know as Newmont Offers to Buy Newcrest Mining ↗

February 06, 2023

Newmont (NEM) stock is in the news Monday as the company reveals plans to purchase Newcrest Mining in a $17 billion deal.

Via InvestorPlace

Takeover News: February Opens With M&A Bang As Gold Miners, REITs Pitch $28 Billion In Deals ↗

February 06, 2023

Mergers and acquisitions are off to a hot start in February as major gold miners, public storage REITs propose $28 billion in deals.

Via Investor's Business Daily

BBIG Stock Alert: VVIP Ventures Acquires Major Outlets From a360 Media ↗

February 06, 2023

Vinco Ventures (BBIG) stock is a hot topic on Monday as investors react to news of it buying major media outlets through a joint venture.

Via InvestorPlace

Why Is Catalent (NYSE:CTLT) Stock Up 20% Today? ↗

February 06, 2023

Catalent (CTLT) stock is soaring more than 20% in early trading on a report that Danaher was interested in buying CTLT.

Via InvestorPlace

Earnings Outlook For Catalent ↗

February 06, 2023

Via Benzinga

Analyst Ratings for Catalent ↗

January 24, 2023

Via Benzinga

Barclays Maintains Overweight Rating for Catalent: Here's What You Need To Know ↗

January 24, 2023

Via Benzinga

Why Shares of Catalent Fell 36% This Week ↗

November 04, 2022

Lowered guidance and earnings concerned investors.

Via The Motley Fool

Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover ↗

February 06, 2023

Danaher is reportedly looking to add to its wheelhouse to compete with Thermo.

Via Investor's Business Daily

Catalent, Faraday Future Intelligent Electric And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

February 06, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. SoundHound AI, Inc. (NASDAQ: SOUN) shares climbed 26.6% to $3.5715 in...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 06, 2023

Via Benzinga

Danaher Shows Interest In Acquiring Catalent Valued At Significant Premium: Report ↗

February 06, 2023

Danaher Corporation (NYSE: DHR) has reportedly expressed interest in acquiring the contract manufacturer Catalent Inc (NYSE: CTLT).

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

February 06, 2023

We're starting off the week with an overview of the biggest pre-market stock movers traders need to know about for Monday!

Via InvestorPlace

Nasdaq Futures Indicate Subdued Start For Wall Street: Jerome Powell's Speech On Tuesday Key Highlight This Week ↗

February 06, 2023

Stock futures indicate major Wall Street indices are expected to open lower this week that will see a crucial speech by Federal Reserve Chair Jerome Powell at the Economic Club of Washing

Via Benzinga

Why PayPal And Coinbase Are Trading Lower; Here Are 20 Stocks Moving Premarket ↗

February 06, 2023

Gainers

Via Benzinga

Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot ↗

January 13, 2023

Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022 ↗

December 19, 2022

Via Benzinga

Can Stocks Buck The Rising Odds Of A Recession? ↗

December 17, 2022

The S&P 500 rose 1.1% and ended the week above its 200-day moving average. Fed Chair Powell spurred a strong rally in stocks on Wednesday, saying interest rates could rise less in December compared to...

Via Talk Markets

Battered FTX's CEO Sam Bankman-Fried Arrested, Elon Musk's SpaceX Mammoth Valuation Of $140B, China Weighs Over $143B In Semiconductor Push: Top Stories Tuesday, Dec. 13 ↗

December 13, 2022

Benzinga Sam Bankman-Fried Arrested In The Bahamas

Via Benzinga

After US Launch Bottlenecks, Novo Nordisk Pushes European Rollout For Wegovy In 2023 ↗

December 13, 2022

Novo Nordisk A/S (NYSE: NVO) will roll out its obesity treatment, Wegovy (semaglutide), in Europe in 2023 to ensure it has enough supply.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 7, 2022 ↗

November 07, 2022

Upgrades

Via Benzinga

Where Catalent Stands With Analysts ↗

November 02, 2022

Over the past 3 months, 11 analysts have published their opinion on Catalent (NYSE:CTLT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022 ↗

November 02, 2022

Upgrades

Via Benzinga

Analyst Ratings for Catalent ↗

November 02, 2022

Over the past 3 months, 8 analysts have published their opinion on Catalent (NYSE:CTLT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's...

Via Benzinga

Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗

November 02, 2022

Gainers

Via Benzinga

Why Catalent Stock Plummeted by Nearly 25% Today ↗

November 01, 2022

Flat revenue growth, a sharp decline in profitability, and reduced guidance combined to make an awful day for the company.

Via The Motley Fool

Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast ↗

November 01, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 70 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 01, 2022

Gainers

Via Benzinga

Unity Biotechnology (UBX) Stock Pops on Positive Study Data ↗

November 01, 2022

Unity Biotechnology (UBX) stock is gaining on Tuesday after the company released results from a Phase 2 clinical trial of UBX1325.

Via InvestorPlace

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.